INTERNATIONAL PATENT: PLIANT THERAPEUTICS, INC. FILES APPLICATION FOR "INTEGRIN INHIBITORS FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS"

GENEVA, April 8 -- PLIANT THERAPEUTICS, INC. (331 Oyster Point Blvd.South San Francisco, California 94080) filed a patent application (PCT/US2024/048217) for "INTEGRIN INHIBITORS FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS" on Sep 24, 2024. With publication no. WO/2025/072206, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEFEBVRE, Eric (c/o Pliant Therapeutics, Inc.331 Oyster Point Blvd.South San Francisco, California 94080), SCHAUB, Johanna Roberta (c/o Pliant Therapeutics, Inc.331 Oyster Point Blvd.South San Fran...